Full-Time

Director – Business Development

Updated on 3/14/2025

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

Compensation Overview

$187k - $282kAnnually

+ Annual Bonus

Senior, Expert

Remote in USA

Remote position; candidates based in the US are preferred.

Category
Business Development
Business & Strategy
Required Skills
Sales
Product Management
Excel/Numbers/Sheets
Requirements
  • BS in Marketing, Business Administration, Healthcare Administration or relevant healthcare discipline required.
  • At least 10 years of experience in the healthcare technology industry
  • At least 10 years of experience in any combination of the following roles: General Management, Product Management, Project Manager, Account Manager, Channel Manager, Sales or Business Development Representative, Market Manager and/or Program Manager
  • At least 5 years of experience in the post-acute care home health and hospice space
  • Proficient computer skills, including intermediate level skill with Microsoft Excel
  • Must be able to travel domestically up to 40% of the time to support partners, trade shows, and customer discussions
  • Equivalent combination of education and experience will be considered.
Responsibilities
  • Leading business development activities for the home health, hospice, and private duty business vertical – recruitment and management of partnerships, closely working with both sales and product management, amongst other stakeholders
  • Leading key strategic initiatives for the company – new market entrance and inorganic growth opportunities, new strategic partnerships
  • Working with internal stakeholders to assess build, buy, partner opportunities for identified areas of need
  • Proactively managing the partnership and integrator ecosystems
  • Assessing strategic partnership candidates for identified areas of need
  • Expanding interoperability leadership in the business vertical.
Desired Qualifications
  • Familiarity with Software as a Service (SaaS) applications and performance criteria preferred.

ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed's offerings include both medical devices and software subscriptions, which provide ongoing support and services. What sets ResMed apart from its competitors is its focus on reducing hospital visits and healthcare costs while improving the quality of life for patients. The company's goal is to enhance patient care and support healthcare professionals and caregivers in managing chronic diseases effectively.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing sleep apnea market boosts demand for ResMed's products.
  • Telehealth adoption aligns with ResMed's cloud-connected device strategy.
  • AI integration in healthcare offers innovation opportunities for ResMed.

What critics are saying

  • Increased competition may impact ResMed's market share.
  • Rising raw material costs could squeeze profit margins.
  • Data privacy concerns may lead to regulatory scrutiny.

What makes Resmed unique

  • ResMed offers cloud-connected devices for sleep apnea and chronic disease management.
  • The company operates in over 120 countries, providing a global healthcare solution.
  • ResMed integrates AI in diagnostics, enhancing personalized treatment options.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

MarketBeat
Feb 28th, 2025
Proficio Capital Partners LLC Invests $50.36 Million in ResMed Inc. (NYSE:RMD)

Proficio Capital Partners LLC invests $50.36 million in ResMed Inc. (NYSE:RMD).

Healthier Tomorrow
Feb 26th, 2025
ResMed Survey: Despite Sleep Problems, Few Willing to Take Proactive Steps

ResMed today unveiled the findings of its fifth annual Global Sleep Survey.

MarketBeat
Feb 22nd, 2025
Alberta Investment Management Corp Invests $2.38 Million in ResMed Inc. (NYSE:RMD)

Alberta Investment Management Corp invests $2.38 million in ResMed Inc. (NYSE:RMD).

India Med Today
Jan 10th, 2025
ResMed launches AirSense 11 for sleep apnea patients

ResMed launches airsense 11 for sleep apnea patients.

ResMed
Jan 6th, 2025
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference